Last month at Partnerships in Clinical Trials (PCT) in Barcelona, Spain, TransCelerate Biopharma CEO, Dalvir Gill explained to contract research and pharma industry representatives that working together to fix issues is the key to simplifying and expediting the clinical trial process. Gill said, “there is this collective understanding that ‘I may have to give on something for the betterment of us all’ that is making that difference. Its not that suddenly everybody has become nice people, its that the pain of not collaborating is no longer bearable.”
TransCelerate has created a number of partnerships with organizations such as the Association of Clinical Research Organizations (ACRO) and the Society for Clinical Research Sites (SCRS) that aid to the improvement of the clinical trial process. In addition, TransCelerate has founder members including sponsors such as AbbVie, AstraZeneca, Pfizer, GSK, J&J, and Roche, who have committed to working with contract research organizations (CROs).
To learn more, click here to read Gareth MacDonald’s article on Outsourcing-Pharma.com.